Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Checkit plc ( (GB:CKT) ) has issued an announcement.
Checkit plc has announced several significant contract renewals and new wins across the UK and US. In the UK, the company secured renewals and expansions with major healthcare providers, increasing their annual contract values and expanding service sites. Notable contracts include renewals with a major private healthcare provider and multiple NHS trusts. In the US, Checkit has successfully entered the market with new contracts with care home providers and secured a significant agreement with CBRE, highlighting its ‘land and expand’ strategy. Additionally, Checkit’s new contract with Canadian Plasma Resources Corporation further cements its leadership in the North American blood plasma industry.
More about Checkit plc
Checkit plc operates in the automated monitoring platform industry, providing solutions for operational leaders, primarily focusing on healthcare and pathology sectors. The company is positioning itself as a leader in medical monitoring services, especially in the North American market, with a notable presence across the UK and US.
YTD Price Performance: -1.39%
Average Trading Volume: 335,407
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £19.17M
For a thorough assessment of CKT stock, go to TipRanks’ Stock Analysis page.
